What is the debt of Mustang Bio this year?
Mustang Bio has a debt level of -6.23 USD this year.
Mustang Bio Debt 2024
Mustang Bio Debt
-6.23 USD
Ticker
MBIO
ISIN
US62818Q1040
WKN
A2DWVA
In 2024, Mustang Bio's total debt was -6.23 USD, a -87.09% change from the -48.3 USD total debt recorded in the previous year.
Mustang Bio Aktienanalyse
What does Mustang Bio do?
Mustang Bio Inc. is a rising biotechnology company that was founded in 2015. Based in Massachusetts, the company specializes in the development of novel genetically modified CAR-T cell therapies for various types of cancer. Mustang Bio's business model is focused on developing and ultimately commercializing groundbreaking, differentiated technologies for the treatment of cancer. The company utilizes its expertise in genetic sequencing research and development, as well as extensive knowledge in the clinical testing of drugs. Mustang Bio has three main divisions: therapeutics, partnerships, and platform technology. The therapeutics division serves as the company's development and marketing arm. Here, innovative CAR-T cell therapies for the treatment of various types of cancer, including hematological and solid tumors, are researched and developed. Mustang Bio has several drug candidates in different phases of clinical development, including MB-106 and MB-107, targeting the treatment of acute myeloid leukemia (AML) and B-cell lymphomas. The partnerships division collaborates with other companies and industry stakeholders to jointly develop new technologies and share research findings. Mustang Bio has already formed several partnerships with other companies, including the Nationwide Children's Hospital and the City of Hope. These partnerships have contributed to advancing research and development in oncology and sharing the costs and risks associated with developing new therapeutics. The platform technology division serves as the technological arm of the company. Here, new technologies and platforms for the discovery and development of innovative therapeutics are developed and improved. This division aims to develop more effective and safer therapies while reducing development time and costs. Mustang Bio takes pride in developing some of the most innovative and advanced technologies for the treatment of cancer. By utilizing genetic sequences and gene editing tools such as CRISPR/Cas9, the company has developed unique CAR-T cell therapies that can specifically target and eliminate tumor cells. The company has already achieved significant milestones, such as receiving Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for MB-107 in the treatment of X-linked severe combined immunodeficiency (XSCID). Additionally, Mustang Bio has signed an exclusive license agreement with St. Jude Children's Research Hospital to develop a new method for oncofusion targeting the treatment of refractory leukemias. Mustang Bio also has a strong leadership team and board of directors consisting of renowned scientists, doctors, and entrepreneurs. The company has also received strong support from its investors and shareholders who believe in the company's potential to change the cancer treatment paradigm. In summary, Mustang Bio is a company dedicated to developing innovative therapeutics for the treatment of cancer. The company leverages its expertise in genome editing research and development, as well as its experience in clinical drug testing, to develop novel, differentiated, and effective CAR-T cell therapies for various types of cancer. Mustang Bio has also built strong partnerships with other companies and industry stakeholders to jointly develop new technologies and therapeutics. Mustang Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Mustang Bio's Debt Structure
Mustang Bio's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Mustang Bio's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Mustang Bio’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Mustang Bio’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Mustang Bio stock
What was the debt of Mustang Bio compared to the previous year?
The debt of Mustang Bio has increased by -87.09% compared to the previous year dropped.
What are the consequences of high debt for investors in Mustang Bio?
High debt can pose a risk for investors of Mustang Bio, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Mustang Bio?
Low debt means that Mustang Bio has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Mustang Bio affect the company?
An increase in debt of Mustang Bio can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Mustang Bio affect the company?
A reduction in debt of Mustang Bio can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Mustang Bio?
Some factors that can influence the debt of Mustang Bio include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Mustang Bio so important for investors?
The debts of Mustang Bio are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Mustang Bio take to change the debt?
To change the debt, Mustang Bio can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Mustang Bio pay?
Over the past 12 months, Mustang Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mustang Bio is expected to pay a dividend of 0 USD.
What is the dividend yield of Mustang Bio?
The current dividend yield of Mustang Bio is .
When does Mustang Bio pay dividends?
Mustang Bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Mustang Bio?
Mustang Bio paid dividends every year for the past 0 years.
What is the dividend of Mustang Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Mustang Bio located?
Mustang Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Mustang Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Mustang Bio from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.
When did Mustang Bio pay the last dividend?
The last dividend was paid out on 11/9/2024.
What was the dividend of Mustang Bio in the year 2023?
In the year 2023, Mustang Bio distributed 0 USD as dividends.
In which currency does Mustang Bio pay out the dividend?
The dividends of Mustang Bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Mustang Bio stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Mustang Bio
Our stock analysis for Mustang Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mustang Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
